Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0842
D

Incomplete Documentation of Informed Consent for Psychotropic Medications

Los Angeles, California Survey Completed on 04-30-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that medical records were complete and accurate for two residents by not verifying that the physician obtained informed consent prior to initiating psychotropic medications. For one resident with anxiety disorder and moderate cognitive impairment, the Verification of Informed Consent for Buspirone did not indicate the prescribing physician's name or confirm that the prescriber obtained informed consent from the resident. The form was signed by the resident but lacked documentation of the prescriber's involvement in the consent process. For another resident with major depression, dementia, and severe cognitive impairment, the Verification of Informed Consent for Mirtazapine, Quetiapine, and Buspirone did not indicate the prescriber and, although signed by the next of kin, did not confirm that the prescriber obtained informed consent from the responsible party. Both the registered nurse supervisor and the director of nursing confirmed that the consent forms were incomplete and did not meet facility policy requirements, which specify that documentation must confirm the physician obtained informed consent and that no blank spaces are left on forms.

An unhandled error has occurred. Reload 🗙